Tuesday, 18 June 2019

India News

  • Wockhardt to market generic of GSK Parkinson's drug

    India |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 29 Aug, 2012

    Mumbai: Pharmaceutical and biotechnology major Wockhardt received US FDA approval for marketing 2mg, 4mg, 6mg, 8mg and 12mg extended-release tablets with generic version of GlaxoSmithKline'...Read more

  • Pharma companies set eyes on China

    India |  Analysis | By BioSpectrum Bureau  | 0 Comment | 19 Jun, 2012

    China reported total of 97 deals worth $6.5 billion, the highest in Asia Pacific, according to a mergermarket report. The country was followed by Australia with 40 deals and India and South...Read more

  • 5 major policy developments of 2012

    India |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 20 Dec, 2012

    The Year 2012 has seen crucial policy changes in the bioscience industry around the world. These changes that have taken place in 2012 hope to have an impact on the businesses of pharma, bi...Read more

  • 50 Indian companies to invest $500mn in the US

    India |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Hyderabad: 50 Indian companies have recently indicated they will collectively invest over $500 million in the US market by either acquiring a US business or setting up their own operations...Read more

  • Lupin gets approval for oral contraceptive

    India |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Bangalore: Pharma major, Lupin, announced that its subsidiary Lupin Pharmaceuticals Inc. (collectively Lupin) has received final approval for its oral contraceptive Kurvelo® Tablets (Levo...Read more

  • What the future holds for the APAC CRO market?

    India |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2013

    The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more

  • Indo-Aussie research to find ovarian cancer cure

    India |  News | By BioSpectrum Bureau  | 0 Comment | 04 Oct, 2012

    Singapore: Scientists at Australia's Queensland University of Technology (QUT) are hot on the trail of a genetic pathway that regulates ovarian cancer stem cells. The university is collabor...Read more

  • joimax goes BRIC and beyond

    India |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Right on time with the soon expected registrations of the joimax products in Brazil - one of the most emerging BRIC economies - the German-based company showed a very successful...Read more

  • Eli Lilly, Strides expand in emerging markets

    India |  News | By BioSpectrum Bureau  | 0 Comment | 06 Dec, 2012

    Bangalore: Eli Lilly and Company and Strides Arcolab have entered into a collaboration to expand delivery of cancer medicines in the emerging markets. As a part of this arrangement, Lilly ...Read more

  • Aventis Pharma renamed to 'Sanofi India Ltd'

    India |  News | By BioSpectrum Bureau  | 0 Comment | 17 May, 2012

    Bangalore: The Sanofi Group recently announced the company's change of name from Aventis Pharma Limited to 'Sanofi India Limited', effective May 11, 2012. Aventis Pharma Limited is the grou...Read more

  • Phoenix's heart repair device trial is underway

    India |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jan, 2013

    Singapore: Phoenix Cardiac Devices, a medical device company with a novel method of repairing leaky heart valves without open-heart surgery, has enrolled its first patient in a clinical tri...Read more

  • Global collaborations is the way forward for drug discovery

    India |  Analysis | By BioSpectrum Bureau  | 0 Comment | 19 Dec, 2012

    Over the last few decades India has reiterated its capabilities in providing dependable and cost effective chemistry services to big pharma through a multitude of outsourcing deals. A large...Read more

  • India caps FDI in pharma at 49%

    India |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jul, 2012

    Bangalore: An inter-ministerial group (IMG) on foreign direct investment (FDI) in pharmaceuticals, headed by Mr Shanktikanta Das, additional secretary, Department of Economic Affairs (DEA),...Read more

  • BMS Foundation awards $1.6 mn to fight diabetes in India

    India |  News | By BioSpectrum Bureau  | 0 Comment | 07 Aug, 2012

    Singapore: Bristol-Myers Squibb (BMS) Foundation will provide $1.6 million in grants to four healthcare institutions in India to help improve diabetes education, prevention and care, increa...Read more

  • Serum Institute acquires Dutch biologics company

    India |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jul, 2012

    Mumbai: Serum Institute of India, the flagship company of the over $1 bn Poonawalla Group and India's largest vaccine company, has acquired Bilthoven Biologicals of Netherlands. Through the...Read more

  • India to examine drug approval procedures

    India |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 14 May, 2012

    Bangalore: India has set up a committee to examine the validity of scientific and statutory basis adopted for approval of new drugs without clinical trials. The government announced the dec...Read more

  • Egypt seeking Indian pharma investment

    India |  News | By BioSpectrum Bureau  | 0 Comment | 05 Dec, 2013

    Singapore: With analysts predicting great growth from overseas for the Indian pharmaceutical industry, Egypt recently joined in the list of countries keen on receiving investment from the s...Read more

  • GE Healthcare unveils first PET/CT designed in India

    India |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

    Singapore: The new Discovery IQ is the result of $15 Million (INR 90 Crores) investment, and 3 years of close collaborative development with Indian nuclear medicine physicians and oncologis...Read more

Podcast

 

Survey Box

Is Asia becoming the centre of healthcare transformation?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls